You are here

Contracts show Valeant's bonuses offer to pharmacy

Documents provide new insights into relationship at the heart of drug maker's share meltdown

BT_20160511_KVVALEANT11_2272388.jpg
The company was the subject of hours of US Senate testimony in April, which included appearances by Mr Pearson (front, right), Valeant's former chief executive.

New York

EMBATTLED drug maker Valeant Pharmaceuticals International offered tens of millions of dollars in incentives to a pharmacy to sell its products even as the relationship between the two was kept private, according to documents released by a Senate committee.

The 818 pages